[4-(1H-benzimidazol-2-ylmethyl)piperidin-1-yl]-[5-(2,3-dihydro-1-benzofuran-5-yl)-3-pyridinyl]methanone
C27H26N4O2 — CID 166211275
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-(1H-benzimidazol-2-ylmethyl)piperidin-1-yl]-[5-(2,3-dihydro-1-benzofuran-5-yl)-3-pyridinyl]methanone
[4-(1H-benzimidazol-2-ylmethyl)piperidin-1-yl]-[5-(2,3-dihydro-1-benzofuran-5-yl)-3-pyridinyl]methanone (PubChem CID 166211275) has the molecular formula C27H26N4O2 and a molecular weight of 438.53 g/mol. Its IUPAC name is [4-(1H-benzimidazol-2-ylmethyl)piperidin-1-yl]-[5-(2,3-dihydro-1-benzofuran-5-yl)-3-pyridinyl]methanone.
Molecular Properties
| Compound Name | [4-(1H-benzimidazol-2-ylmethyl)piperidin-1-yl]-[5-(2,3-dihydro-1-benzofuran-5-yl)-3-pyridinyl]methanone |
|---|---|
| PubChem CID | 166211275 |
| Molecular Formula | C27H26N4O2 |
| Molecular Weight | 438.53 g/mol |
| Exact Mass | 438.21 |
| IUPAC Name | [4-(1H-benzimidazol-2-ylmethyl)piperidin-1-yl]-[5-(2,3-dihydro-1-benzofuran-5-yl)-3-pyridinyl]methanone |
| SMILES | O=C(c1cncc(-c2ccc3c(c2)CCO3)c1)N1CCC(Cc2nc3ccccc3[nH]2)CC1 |
| InChI | InChI=1S/C27H26N4O2/c32-27(22-15-21(16-28-17-22)19-5-6-25-20(14-19)9-12-33-25)31-10-7-18(8-11-31)13-26-29-23-3-1-2-4-24(23)30-26/h1-6,14-18H,7-13H2,(H,29,30) |
| InChIKey | MJUBKZLWSHBBKA-UHFFFAOYSA-N |
| XLogP | 4.65 |
| TPSA | 71.11 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.53 |
| LogP ≤ 5 | 4.65 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166211275 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.